CS-014
N/A
Report date: 2025/04/27 13:33:29
NME
Base Information
Drug NameCS-014
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmeriti Bio AB
China Registration ClassN/A
Develop Information
Active CompaniesCereno Scientific Ab
Inactive CompaniesEmeriti Bio AB
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A